Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Pegenzileukin by Sanofi for Oropharyngeal Cancer: Likelihood of Approval
Pegenzileukin is under clinical development by Sanofi and currently in Phase II for Oropharyngeal Cancer. According to GlobalData, Phase II...
Data Insights
Pegenzileukin by Sanofi for Cutaneous Squamous Cell Carcinoma (cSCC): Likelihood of Approval
Pegenzileukin is under clinical development by Sanofi and currently in Phase II for Cutaneous Squamous Cell Carcinoma (cSCC). According to...